KATHLEEN WUCHER provides assistance on EU and FDA matters in the area of drug and medical device compliance and enforcement. She supports the Life Sciences team when advising global life sciences clients with compliance projects and cross-border internal investigations, including internal investigations into life sciences companies interactions with healthcare professionals and government officials and internal investigations for life sciences companies following security incidents. In addition, Kathleen drafts and manages the bi-annual best practices benchmarking reports for each of Sidley’s Life Sciences Legal Networks, based on input provided by member companies regarding clinical trials, pharmacovigilance, data privacy, antitrust/competition and anti-corruption/anti-bribery.
Prior to joining Sidley, Kathleen worked in the antitrust practice group at a top plaintiff law firm in Washington, D.C., where she focused on discovery and evidentiary-related aspects of litigation and deposition preparation. Kathleen also practiced at a leading international law firm in Brussels, focused on cartel investigations brought by the European Commission and international mergers.
*Only admitted to practice in Washington, D.C., and England and Wales. Not admitted to practice in Belgium.